PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $275,000 | -67.7% | 87,446 | -66.7% | 0.03% | -75.2% |
| Q4 2019 | $852,000 | +419.5% | 262,508 | +245.3% | 0.12% | +254.5% |
| Q3 2019 | $164,000 | -37.2% | 76,020 | -8.5% | 0.03% | +6.5% |
| Q2 2019 | $261,000 | -66.0% | 83,060 | -59.8% | 0.03% | -72.3% |
| Q1 2019 | $768,000 | +631.4% | 206,473 | +358.1% | 0.11% | +2140.0% |
| Q2 2018 | $105,000 | – | 45,069 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |